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The Bacteroidales produce an N-
acylated derivative of glycine with 
both cholesterol-solubilising and 
hemolytic activity
Alli Lynch1,2, Elaine Crowley2, Eoghan Casey2, Rafael Cano3, Rachel Shanahan3,  
Ger McGlacken3, Julian R. Marchesi  4 & David J. Clarke  1,2
The contribution of the gut microbiota to the metabolism of cholesterol is not well understood. In this 
study, we identify 21 fosmid clones from a human gut microbiome metagenomic library that, when 
expressed in Escherichia coli, produce halos on LB agar supplemented with 0.01% (w/v) cholesterol 
(LBC agar). Analysis of 14 of these clones revealed that they all share a fragment of DNA with homology 
to the genome of Bacteroides vulgatus. The gene responsible for halo production on LBC agar, named 
choA, was identified as an N-acyltransferase known to produce an acylated glycine molecule called 
commendamide. In this study we show that commendamide is capable of producing a halo on LBC 
agar suggesting that this molecule is solubilizing the cholesterol micelles in LBC agar. We also show 
that commendamide is responsible for the previously described hemolytic activity associated with the 
choA orthologue in Bacteroides fragilis. A functional analysis of ChoA identified 2 amino acids that are 
important for commendamide biosynthesis and we present phylogenetic and functional data showing 
that orthologues of choA are found only in the order Bacteroidales. Therefore, the production of 
commendamide may be an adaptation to the environments colonized by the Bacteroidales, including 
the mammalian gut.
The gut microbiota is an ecosystem rich in microbial diversity that has the potential to encode for a wide range 
of metabolic activities that may impact on host health and/or development1–4. Many activities associated with 
the gut microbiota are likely to be novel and may not be predicted by normal in silico DNA sequence analysis. 
Therefore, functional metagenomics can be used as a tool to identify novel activities in the microbiota. In this way 
several important and novel microbial activities that impact on host physiology have been identified5,6.
Cholesterol is an important structural component of mammalian cell membranes and it is either synthesised 
“de novo” in the body or it is acquired from dietary sources. Cholesterol metabolism is very important for eukary-
otes as it is a precursor for vitamins, bile acids, and steroid hormones. However, high serum cholesterol is also an 
important risk factor for developing Coronary Heart Disease, a leading cause of death worldwide. Although the 
human gut microbiota can affect the physiology of the human host, the contribution of the gut microbiota to the 
metabolism of cholesterol is not well understood7. Germ-free C57BL/6 mice fed a high-fat diet had higher levels 
of cholesterol in their fecal pellets compared to conventional mice on the same diet suggesting that the presence 
of a microbiota can reduce the levels of cholesterol excreted in the feces8. However, a specific role, if any, for the 
microbiota in cholesterol metabolism is still not clear. Some members of the gut microbiota have been shown to 
have cholesterol reductase activity resulting in the reduction of cholesterol to coprostanol9–12. For example a strain 
of Bacteroides sp. was isolated from human feces and was shown to be able to reduce cholesterol to coprostanol, 
although the gene encoding this activity was not identified13.
In this study we have screened a functional metagenomic library constructed from the microbial DNA iso-
lated from the feces of a healthy human male volunteer for activities that affect cholesterol solubilisation. In total 
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14 clones were identified and all of these clones mapped to the same 9-gene DNA fragment with strong homology 
to the genome of Bacteroides vulgatus, a member of the healthy human gut microbiota14. Further molecular anal-
ysis identified a single gene from this region that was responsible for the observed activity and this gene has been 
called choA. The choA gene has recently been shown to encode an amino acid N-acyltransferase that produces 
N-acyl-3-hydroxy-palmitoyl glycine or commendamide15. In this study we show that the production of commen-
damide is responsible for the observed cholesterol solubilizing activity and we report that commendamide also 
has strong hemolytic activity. We report the identification of amino acid residues that are important for ChoA 
activity and we present functional data to show that the phylogenetic distribution of choA is limited to the order 
Bacteroidales, a group of bacteria associated with the mammalian gut. This suggests that ChoA activity may be 
particularly relevant to life in this environmental niche.
Results
Isolation of fosmids with potential cholesterol-solubilizing activity. The solubilisation of choles-
terol is important for normal recycling and uptake with bile salts and phospholipids playing an important emul-
sifying role in mediating cholesterol solubility and reabsorption in vivo16. To determine what role, if any, the gut 
microbiota might have in cholesterol metabolism we screened a metagenomic library for encoded activities that 
might contribute to the solubilisation of cholesterol. The metagenomic library was constructed from microbial 
DNA isolated from the fecal sample of a heathy male human volunteer and the library was maintained in the 
heterologous host, E. coli EPI300. LB agar becomes turbid after the addition of 0.01% (w/v) cholesterol (through 
the formation of cholesterol micelles or crystals)17,18. Therefore, we screened our metagenomic library for DNA 
that encoded proteins which affected the formation of these micelles. Individual E. coli clones containing fosmids 
were picked onto LB agar plates containing 0.01% (w/v) cholesterol (LBC agar) and, after incubation for 48 h at 
37 °C, each colony was scored for the presence/absence of a zone of clearing around the bacterial colony. In total 
41,472 clones (average insert size = 35kbp) were screened (1,451Mbp of microbiome DNA in total) and 21 clones, 
that produced a zone of clearing around the bacterial colony, were identified (see Fig. 1). The presence of a zone 
of clearing was considered indicative of the production of potential cholesterol-solubilizing activity by a gene(s) 
expressed from DNA present in the fosmid clone.
Identification of choA. The DNA fragment present in 14 out of the 21 clones was identified by 
end-sequencing of the fosmid insert and BLAST analysis. All of the sequenced DNA fragments exhibited strong 
homology (>99% identity) to the same region of genomic DNA from Bacteroides vulgatus ATCC8482 pre-
dicted to contain the ORFs, Bvu_RS07105 to Bvu_RS07145 (see Fig. 2). Bvu_RS07105 and Bvu_RS07110 are 
predicted to encode proteins with homology to rRNA small subunit methyltransferase H and MraZ respectively. 
Bvu_RS07115 is predicted to encode a glycerol acyltransferase and Bvu_RS07220 is annotated as a hemolysin. 
Bvu_RS07125 and Bvu_RS07130 are predicted to encode proteins involved in nucleotide metabolism, dGTP 
triphosphohydrolase and dUTP nucleotidohydrolase, respectively. Bvu_RS07135 and Bvu_RS07140 are predicted 
to encode hypothetical proteins and Bvu_RS07145 is predicted to encode EnvC, a septal ring factor involved 
in the activation of murein amidases. In an unbiased approach to link the cholesterol-solubilizing activity with 
a specific gene in this region we selected a fosmid (labelled 36.9E) and undertook in vitro random transposon 
mutagenesis. The mutated fosmid pool was electroporated into EPI300 cells and 2 mutants (out of a total of 960 
mutants screened) that were unable to produce the zone of clearing on LBC agar were identified. The site of trans-
poson insertion in these mutants was identified by DNA sequencing and was shown to be within Bvu_RS07120 
(see Fig. 2A). The Bvu_RS07120 gene was cloned into pTRC99a (under the control of the IPTG-inducible ptrc 
promoter) and expression of Bvu_RS07120 resulted in a zone of clearance when EPI300 cells containing the 
plasmid were cultured on LBC agar plates (see Fig. 2B). Therefore, we have identified an ORF from B. vulgatus, 
Figure 1. Halo production on LBC agar. EPI100 cells carrying a fosmid from a human gut metagenomic library 
were screened on LB agar containing 0.01% (w/v) cholesterol for the production of a halo, indicative of the 
presence of a gene(s) on the fosmid that encodes a factor that has activity against cholesterol. EPI100 carrying 
fosmid 36.9E is shown as an example of the type of halo observed.
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Bvu_RS07120, that is linked with the solubilisation of cholesterol and we have renamed the gene choA (and the 
plasmid carrying choA was named pTRC-choA).
ChoA produces a bioactive amine that solubilises cholesterol. To determine whether ChoA had 
an enzymatic activity that directly affected the solubility of cholesterol we purified the ChoA protein using a 
N-terminal 6XHis tag. The 6His-ChoA protein was overproduced and purified using Ni-affinity chromatogra-
phy. The application of the purified protein directly on to LBC agar plates did not produce a zone of clearing 
suggesting that ChoA does not directly modify cholesterol (see Supplementary Figure S1). An alternative possi-
bility is that ChoA produces a molecule that affects the solubility of cholesterol. Interestingly choA was recently 
described in an independent functional metagenomic screen looking for genes in the human gut microbiome 
that produced LPS-independent activators of NF-kB15. In this study the authors identified choA (called Cbeg12) 
as a gene encoding an amino acid acyltransferase that produces the bioactive amine, N-acyl-3-hydroxy-palmitoyl 
glycine or commendamide. Commendamide was shown to activate NF-kB through the G-protein coupled recep-
tor, GPCR G2A/13215. To confirm that choA is producing commendamide in our system, cell-free supernatants 
(CFS) of cultures of E. coli carrying either the pTRC99a vector or the pTRC-choA plasmid were applied to a 
HEK293 cell line carrying a SEAP reporter gene under the control of a NF-kB sensitive promoter. As seen in 
Fig. 3A there is a significant increase in SEAP expression when the CFS from E. coli cultures expressing choA is 
added to the cell line compared to the CFS of E. coli cultures carrying the pTRC99a vector thus confirming the 
link between choA and NF-kB activation (see Fig. 3A). Moreover, the application of an aliquot of the ethyl ace-
tate extract of CFS from cultures of E. coli carrying the pTRC99a-choA plasmid resulted in a zone of clearing on 
LBC agar plates (see Fig. 3B). Analysis of the ethyl acetate extract using high-resolution mass spectrometry also 
identified a peak, specific for the pTRC-choA extract, with a predicted mass that was similar to commendamide 
(see Supplementary Figure S2). We wanted to confirm that the production of commendamide by ChoA was 
responsible for the zone of clearing observed on LBC agar plates. To address this, we added 50 μl of a 10 mg ml−1 
solution of synthetic commendamide (>95% purity as determined by NMR) to a well in a LBC agar plate. A 
zone of clearing, indicating cholesterol solubilisation, was observed around the well containing commendamide 
(see Fig. 3C). Importantly, the DMSO carrier and other acylated compounds tested (N-acetylglycine (ACG), 
N-palmitoylethanolamide (PAE) and N-palmitoylglycine (PAG)) did not produce zones of clearing when applied 
to LBC agar plates indicating that the activity of commendaminde on LBC agar is specific. Therefore, our data 
confirms that ChoA produces a molecule, N-acyl-3-hydroxy-palmitoyl glycine or commendamide, that has the 
ability to solubilize cholesterol.
ChoA is distributed throughout the Bacteroidales. To determine the phylogenetic distribution of 
ChoA we undertook TBLASTN analysis of the bacterial genomes available at NCBI using the predicted amino 
acid sequence of ChoA from B. vulgatus as our query. Potential orthologues (with E vales < 10−21) were found in 
genomes from Bacteroides (taxaid: 816), Prevotella (taxaid: 838), Porphyromonas (taxaid: 836), Parabacteriodes 
(taxaid: 375288), Alistipes (taxaid: 239759) and Flavobacterium (taxaid:237). Orthologues were also identified dis-
tributed sporadically in the Proteobacteria e.g. Vibrio harveyi. Comparison of the predicted amino acid sequences 
confirmed the presence of ChoA orthologues in Bacteroides thetaiotamicron VPI5482 (BT_3459), Bacteroides 
intestinalis DSM17393 (BACINT_RS03885), Parabacteroides johnsonii DSM18315 (PARABACJOHN_RS00935), 
Prevotella oralis ATCC33269 (HMPREF0663_RS05760), Porphyromonas catoniae ATCC51270 (HMPREF0636_
RS00930) and Alistipes putredinis DSM17216 (ALLIPUT_RS10580) (see Table 1). All of these bacteria are mem-
bers of the Bacteroidales. The ChoA orthologues in Flavobacterium and V. harveyi were longer than the query 
sequence (587 and 604 amino acids in V. harveyi and Flavobacterium, respectively, compared to 323–332 amino 
acids in the Bacteroidales) and had only 25.33% and 25.17% amino acid identity with ChoA from B. vulga-
tus, respectively (see Table 1). Therefore, our data suggests that the choA gene is restricted to the Bacteroidales. 
Figure 2. Identification of the gene required for the production of the halo on LBC agar. (A) Fosmid 36.9E 
was subjected to in vitro transposon mutagenesis and mutants that did not produce a halo on LBC agar were 
identified. Sequencing identified that the transposons in these mutants had inserted into a gene with homology 
to Bvu_RS07120 from Bacteroides vulgatus. (B) The Bvu_RS07120 gene was cloned into pTRC99a, transformed 
into EPI100 and tested for the production of a halo on LBC agar.
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Indeed, when expressed in E. coli, all of the choA orthologues cloned from the Bacteroidales produced a halo on 
LBC agar plates suggesting the production of commendamide, although the halos associated with the orthologues 
from P. johnsonii and P. catoniae are clearly smaller in size (see Fig. 4).
Structure-function analysis of ChoA. Phyre2 analysis produced a model for ChoA (confidence = 99.7%) 
based on the structure of LasI, an autoinducer synthetase from Pseudomonas aeruginosa (LasI; PDB entry 1ro5)19. 
LasI is an acyl-CoA N-acyltransferase that is required for the synthesis of the N-acyl homoserine lactone signaling 
molecule involved in quorum sensing20. The structural homology between LasI and ChoA extends from residues 
29–184 of ChoA indicating that the active site required for acyltransferase activity is likely to be localized to this 
region. ClustalW analysis of the different ChoA homologues from the Bacteroidales reveals several blocks of 
conserved amino acids in this region including the 136-ELGRSFV-142 motif (see Fig. 5A). A similar motif has 
recently been shown to be required for the activity of the COG3176 family of N-acyltransferases21. To test the 
functionality of this motif in ChoA we undertook site-directed mutagenesis whereby Glu136 (E136) and Arg139 
(R139) were changed to Ala. The mutated choA genes were cloned into pTRC99a and expressed in EPI300 cells 
and plated on LBC agar. As can be seen in Fig. 5B both the E136A mutation and the R139A mutation completely 
Figure 3. Commendamide activates NF-kB and produces a halo on LBC agar. (A) The cell-free supernatant 
(CFS) of E. coli EPI300 carrying pTRC-choA or the vector control were extracted with ethyl acetate and applied 
to monolayers of a HEK293 cell containing the SEAP reporter gene under the control of a NF-kB sensitive 
promoter. The level of SEAP expression is greater from cells treated with CFS from pTRC-choA expressing 
bacteria as compared to the pTRC99a vector. The experiment was carried out in triplicate and the error bars 
represent the standard deviation. (***P < 0.001). (B) A 50 μl aliquot of a crude ethyl acetate extract of the 
CFS from E. coli containing the pTRC99a-choA plasmid or the vector control was added to a well that had 
been made in a LBC agar plate. The plate was incubated at room temperature and the photograph was taken 
after 12 h (although the halo was seen to form within 1–2 h). (C) Synthetic commendamide produces a halo 
on LBC agar. Therefore 500 µg (50 µl of a 10 mg ml−1 solution) of synthetic commendamide and similar 
compounds were added to a well in a LBC agar plate and incubated at 37 °C for 48 h before the presence/
absence of a halo was determined. DMSO: carrier control; COM: commendamide; PAG: N-palmitoylglycine; 
PAE: palmitoylethanolamide; ACG: N-acetylglycine. This experiment was repeated at least 3 times and a 
representative experiment is shown here.
Strain* Ap Pc Pj Po Bv Bt Bi Fl Vh
Ap 100 52.38 52.09 50.16 48.40 51.24 52.08 24.66 30.34
Pc 52.38 100 59.01 55.66 57.98 58.05 56.75 25.41 27.42
Pj 52.09 59.01 100 60.87 66.15 65.22 64.29 25.67 25.17
Po 50.16 55.66 60.87 100 74.54 70.43 74.70 25.91 26.51
Bv 48.40 57.98 66.15 74.54 100 77.61 81.60 25.33 25.17
Bt 51.24 58.05 65.22 70.43 77.61 100 82.32 26.67 27.52
Bi 52.08 56.75 64.29 74.70 81.60 82.32 100 26.33 25.84
Fl 27.00 25.41 25.67 25.91 25.33 26.67 26.33 100 34.08
Vh 30.34 27.42 25.17 26.51 25.17 27.52 25.84 34.08 100
Table 1. Percent identity matrix for ChoA orthologues. *Ap: Alistipes putredinis; Pc: Porphyromonas catonaie; 
Pj: Parabacteroides johnsoni; Po: Prevotella oralis; Bv: Bacteroides vulgatus; Bt: Bacteroides thetaiotaomicron; 
Bi: Bacteroides intestinalis; Fl: Flavobacterium and Vh: Vibrio harveyi.
www.nature.com/scientificreports/
5SCIentIfIC RepoRTS | 7: 13270  | DOI:10.1038/s41598-017-13774-6
abolished the production of a zone of clearing on LBC agar confirming a role for these amino acids in the activ-
ity of ChoA. Importantly neither mutation had any effect on the stability of the ChoA protein as determined by 
immunoblotting (see Fig. 5C). We also tested the CFS from cells expressing the choA R139A mutant for the acti-
vation of NF-kB and confirmed that the level of commendamide produced is reduced to below the detection limit 
of this assay (see Fig. 5D). Therefore, we have identified 2 amino acids, conserved in all ChoA orthologues, that 
are required for the production of commendamide thus defining part of the active site of this protein.
ChoA has hemolytic activity. In B. vulgatus the choA gene (Bvu_RS07120) is annotated as a putative 
hemolysin and the ChoA orthologue in Bacteroides fragilis has been reported to have hemolytic activity22,23. 
To confirm the hemolytic activity of ChoA, we plated E. coli EPI300 cells containing pTRC99a and the clones 
expressing the different choA orthologues on LB agar plates incorporating 5% (v/v) horse blood. After 48 h incu-
bation at 37 °C a clear zone of hemolysis was observed around colonies expressing all of the choA orthologues 
except the vector control (see Fig. 6A). We also tested ChoA E136A and ChoA R139A for hemolytic activity and 
it is clear that hemolysin activity is greatly reduced/absent from these mutants confirming that these residues 
have an important role in the activity of ChoA (see Fig. 6B). Moreover, we could not detect any hemolytic activity 
when 50 μg ml−1 of the purified ChoA protein was incubated with horse blood in PBS (see Fig. 6C). Using the 
same assay, we could measure hemolysis (at a level of 49% total hemolysis) when commendamide was added at 
a concentration of 10 μg ml−1 and 100% hemolysis at all concentrations >10 μg ml−1 (see Fig. 6C). Finally, com-
mendamide was tested using blood plates and a clear zone of hemolysis could be detected around the well (see 
Fig. 6D). In contrast similar acylated molecules did not produce a zone of clearing around the well suggesting that 
the potent hemolytic activity observed was specific to commendaminde (see Fig. 6D). Therefore, we propose that 
the hemolytic activity associated with ChoA is due to the production of commendamide.
Figure 4. ChoA orthologues from across the Bacteriodales are associated with cholesterol solubilisation. E. 
coli EPI300 expressing different orthologues of choA were grown on LBC agar at 37 °C for 48 h. An orthologue 
was scored positive for commendamide production if there was a halo of any size observed around the colony. 
As a comparison there is no halo around the vector control colony. Bv: Bacteroides vulgatus (YP_001298717.1); 
Bt: Bacteroides thetaiotamicron (NP_812371.1); Bi: Bacteroides intestinali (ZP_03013295.1)s; Po: Prevotella 
oralis (WP_004369353.1); Pc: Porphyromonas catonaie (WP_044167815.1); Pj: Parabacteroides johnsoni 
(WP_008156608.1); Ap: Alistipes putredinis (WP_004329950.1); vector: pTRC99a.
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Discussion
Commendamide was previously identified as a molecule, produced by Bacteroides spp., that activates NF-kB 
through the GPCR protein G2A/13215. In this study we have confirmed these observations but we have also 
shown that commendamide production results in a halo on LB agar incorporating 0.01–0.02% (w/v) cholesterol 
(LBC agar plates) and hemolysis on blood agar plates. LBC agar plates have a turbid appearance and this turbidity 
is due to the formation of cholesterol micelles. Cholesterol has been shown to self-associate into micelles in aque-
ous solutions and the critical micellar concentration of cholesterol in aqueous solutions is 25–40 nM18,24. In this 
study we routinely use concentrations of cholesterol ranging between 0.01–0.02% (w/v) (equivalent to approx-
imately 250–500 μM) in the LBC agar suggesting that cholesterol is forming micelles in our system. Therefore, 
we propose that commendamide production results in the solubilisation of these cholesterol micelles resulting 
in the observed halo. In addition, commendamide can also lyse red blood cells, an activity that we have shown is 
genetically linked to cholesterol solubilisation, and it is likely that hemolysis is a result of the solubilisation of the 
red blood cell membrane. However, it is not yet known whether the solubilisation activity of commendamide is 
specific for cholesterol and this is currently being investigated in the laboratory.
The Bacteroidales contains a number of bacterial species (e.g. Bacteroides, Alistipes) that represent a significant 
fraction of the human gut microbiota. Indeed, the Bacteroides genus has been identified as the most abundant 
genus in the healthy gut microbiota14,25. Therefore, as choA is found only in the Bacteroidales, ChoA activity 
may represent an important function in the human gut. ChoA is a member of the long-chain N-acyl amino acid 
synthase (NAS) group of enzymes15,26. Functional metagenomics screens of environmental DNA have identified 
a number of NAS proteins that have been shown to add long-chain acyl groups to different amino acids e.g. 
NasW acylates tryptophan, NasR acylates arginine, NasP acylates phenylalanine and NasY1 acylates tyrosine26–28. 
Interestingly, the occurrence of NAS activity is also thought to be a common phenomenon amongst environ-
mental metagenomic libraries28. However, a Clustal Omega alignment of ChoA, NasY1, NasR, NasP and NasW 
revealed very little pairwise homology (<25% identity) suggesting that these enzymes do not share a common 
ancestor (see Supplementary Table S2). It has not yet been determined whether different acylated amino acids 
have the same activity as commendamide. However, our data does indicate that both cholesterol solubilisation 
and hemolysis requires the 3-hydroxy substitution present on the palmitoyl chain attached to the glycine as we 
Figure 5. The identification of amino acids important for the activity of ChoA. (A) Clustal analysis of ChoA 
orthologues from the Bacteroidales. The conserved region discussed in the text is highlighted by the box 
and species annotations are as indicated in in Fig. 4. (B) Activity of EPI300 cells expressing choA and mutant 
derivatives on LBC agar plates. Plates were inoculated with the appropriate bacteria and incubated at 37 °C for 
48 h. (C) Immunoblot analysis of total cell extracts from overnight cultures of E. coli EPI300 containing (1) 
pTRC99a-choA, (2) pTRC99a, (3) pTRC-choAE136A and (4) pTRC-choAR139A. (D) The cell-free supernatant 
(CFS) of E. coli EPI300 expressing choA, choAR139A or the vector control were extracted with ethyl acetate 
and applied to monolayers of a HEK293 cell containing the SEAP reporter gene under the control of a NF-kB 
sensitive promoter. The experiment was carried out in triplicate and the error bars represent the standard 
deviation. (***P < 0.001).
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have shown that N-palmitoylglycine is inactive (see Figs 3 and 6). Therefore, commendamide activity does not 
appear to be commonly associated with acylated amino acids.
It should be noted that all of the commendamide phenotypes reported here and elsewhere15 are associ-
ated with the heterologous overexpression of choA in E. coli. Therefore, the physiological role of choA in the 
Bacteroidales is still unknown. Commendamide has been detected in the supernatants of Bacteroides cultures 
after an extended stationary phase suggesting that this molecule may be secreted15. One possible function of 
commendamide may be to contribute to the solubilisation of cholesterol in the host in order to aid reabsorption 
in the gut29. Moreover, the timing of commendamide production suggests that this molecule may contribute to 
the adaptation of Bacteroides to starvation. Indeed, it was shown that a deletion mutant in B. fragilis that encom-
passed both the hlyB and choA homologues in this bacterium has a very strong growth phenotype22. Alternatively, 
we have noted that the structure of commendamide resembles that of the AHL molecules used during quorum 
sensing in many Gram negative bacteria. ChoA does have sequence, and predicted structural, homology with 
the enzymes known to produce the quorum-sensing AHLs (i.e AHL synthases) and it has been suggested that 
acylated amino acids may function as quorum sensing-like signals in some bacteria26. AHLs diffuse across the 
bacterial membranes in order to accumulate in the environment and it is possible that commendamide secretion 
may employ a similar mechanism. However, some acylated amino acids have been shown to integrate into the 
membrane bilayer in order to replace phospholipids during periods of phosphate limitation30,31. Therefore, it is 
also possible that the primary reservoir of commendamide molecule is the bacterial membrane and commen-
damide release may be a consequence of cell lysis.
Genome analysis indicates that choA is always found immediately downstream from another gene, pre-
dicted to encode a member of the lysophospholipid acyltransferase (LPLAT) superfamily (CDD:302626)22 (see 
Supplementary Figure S3). Moreover, the longer ChoA orthologues from V. harveyi and Flavobacterium have 
homology to LPLAT at the N-terminus with homology to ChoA at the C-terminus suggesting that these activities 
may be coupled (see Supplementary Figure S3). In Sinorhizobium meliloti the production of ornithine lipid (OL) 
has been shown to require two acyltrasferases, OlsA and OlsB. OlsB catalyses the first step in OL biosynthesis, 
the addition of a 3-hydroxy fatty acyl group to the α-amino group of ornithine resulting in the formation of 
lyso-OL32. OlsA has LPLAT activity that transfers a fatty acyl group to the 3-hydroxy group of the fatty acid in 
lyso-OL, thus forming the diacylated OL33. In contrast, Serratia proteamaculans uses a single bifunctional protein, 
with both LPLAT and acyltransferase activities, to produce OL34. Interestingly lyso-OL has been reported to have 
Figure 6. Commendamide has haemolytic activity. (A) EPI300 expressing different orthologues of choA, 
screened on horse blood agar. Bv: Bacteroides vulgatus; Bt: Bacteroides thetaiotamicron; Bi: Bacteroides 
intestinalis; Po: Prevotella oralis; Pc: Porphyromonas catonaie; Pj: Parabacteroides johnsoni; Ap: Alistipes 
putredinis; vector: pTRC99a. (B) Hemolytic activity of EPI300 cells expressing choA and mutant derivatives as 
determined using horse blood agar. Agar plates were inoculated with the appropriate bacteria, cultured at 37 °C 
for 48 h before the presence/absence of a halo was scored. (C) Purified ChoA and commendamide (COM), 
at the indicated concentrations, was added to 1 ml of 2% (v/v) defibrinated horse blood in PBS and hemolysis 
was measured after 4 h incubation at 37 °C. Samples were compared to positive (blood cells lysed with water) 
and negative (no protein for ChoA and DMSO for COM) controls. (D) Commendamide and other acylated 
compounds were tested for hemolytic activity on horse blood agar. Therefore, 500 µg (50 µl of a 10 mg ml−1 
solution) of each compound was added to a well in a horse blood agar plate and incubated at 37 °C for 48 h 
before the presence/absence of a halo was determined. DMSO: carrier control; COM: commendamide; PAG: 
N-palmitoylglycine; PAE: palmitoylethanolamide; ACG: N-acetylglycine. This experiment was repeated 3 times 
and a representative experiment is shown here.
www.nature.com/scientificreports/
8SCIentIfIC RepoRTS | 7: 13270  | DOI:10.1038/s41598-017-13774-6
hemolytic activity (although we have not tested whether lyso-OL can solubilize cholesterol) whilst the diacylated 
OL is not hemolytic but does have haemagglutination activity35. Therefore, we propose that, in the Bacteroidales, 
ChoA is required for the production of commendamide (a lyso-glycine lipid) and the acyltransferase encoded 
by hlyB may conjugate a fatty acyl group to the hydroxyl-group on the palmitoyl moiety of commendamide to 
produce glycine lipid (GL). However, the production of GL remains to be confirmed experimentally and further 
work on the role of commendamide and/or GL in Bacteroides is currently under way in the laboratory.
Methods
Bacterial Strains and growth conditions. Bacteroides vulgatus ATCC 8482 and Bacteroides thetaiotaomi-
cron VPI 5482 were routinely cultured in Brain Heart Infusion media (Sigma-Aldrich), supplemented with hemin 
(5 μg ml−1), cysteine (0.1% (w/v)), and sodium bicarbonate (0.2% (w/v)), and grown under anaerobic conditions 
at 37 °C. E. coli EPI300 was grown, aerobically at 37 °C, in Lysogeny broth (LB), supplemented, where appropriate, 
with ampicillin (100 μg ml−1) and chloramphenicol (12.5 μg ml−1).
Metagenomic screen. A human gut metagenomic library, previously constructed from the feces of a healthy 
male6, expressed in E. coli EPI300 was screened for clones that could produce a halo around a colony on LBC agar 
(i.e. LB agar supplemented with 0.01% (w/v) cholesterol (Sigma-Aldrich)). LBC agar has a turbid appearance due 
to the formation of insoluble cholesterol micelles. Fosmid clones from the library were spotted onto Q-trays con-
taining LBC agar, using a Genetix QPIX2 colony picking robot, and incubated at 37 °C for 48 h. After incubation, 
clones were visually examined for the presence of a clear halo around a colony. All of the potential positive clones 
were re-streaked from the original library onto LBC agar plates to conform halo production. The DNA fragment 
in each fosmid was identified by end-sequencing using the T7 and M13R primers (GATC Biotech).
In vitro Transposon Mutagenesis. In order to identify the gene(s) responsible for the observed activity 
one fosmid, 36.9E, was subjected to in vitro transposon mutagenesis using the EZ-Tn5™ Tnp Transposome™ Kit 
(Epicentre), according to the manufacturer’s instructions. Individual mutants were screened for activity and, from 
960 mutants screened, 2 were identified (7.3 G and 8.11 C) that could no longer produce a halo on LBC agar. The 
exact location of the transposon insertion in these mutants was identified by DNA sequencing using the KAN-2 
FP-1 and KAN-2 RP-1 forward and reverse (respectively) transposon-specific primers (Epicentre).
Cloning choA orthologues and mutant construction. The different choA orthologues identified in 
this study were amplified by PCR and cloned under the control of the IPTG-inducible Ptrc promoter present 
in pTRC99a36. Primers used for cloning were purchased from MWG-Biotech, and are listed in Supplementary 
Table S1. Genomic DNA was isolated from Bacteroides vulgatus and Bacteroides thetaiotamicroan using GenElute 
Bacterial Genomic DNA Kit (Sigma-Aldrich). In all other cases genomic DNA was purchased from DSMZ. Site 
directed mutagenesis was carried out on the cloned choA gene from B. vulgatus using QuikChange® Site-Directed 
Mutagenesis Kit (Agilent), according to manufacturer’s instructions and mutations were confirmed by sequenc-
ing (GATC Biotech).
Blood Plate Assays. For agar-based hemolysin assays Tryptic Soy agar was supplemented with 5% (v/v) 
defibrinated horse blood (Cruinn) and 20 μM IPTG, to induce expression of choA. Overnight cultures, expressing 
the relevant choA clone, were pelleted by centrifugation (1000 g, 5 mins, at room temperature), resuspended in 
PBS and adjusted to an OD6000= 1. An aliquot of 5 μl of each culture was spotted onto the blood plate (and LBC 
agar plate where appropriate), in biological triplicate, along with a negative control. The plates were incubated at 
37 °C for 48 h, and visually inspected for hemolysis or halos.
Liquid Hemolysin Assay. The hemolytic activity of purified ChoA and commendamide was assessed using 
a liquid hemolysin assay. Reaction mixtures containing 2% (v/v) defibrinated horse blood in PBS were set up and 
purified ChoA or commendamide was added to the required concentration. For the positive control (i.e. 100% 
hemolysis) red blood cells were lysed in water and for the negative control, PBS (carrier for the purified ChoA) or 
DMSO (carrier for the commendamide) was added to the reaction mixture. All reaction mixtures were at a final 
volume of 1 ml. The reactions were incubated at 37 °C for 4 hours, before the samples were centrifuged for 3 min 
at 1000 g to gently spin out any intact red blood cells. The release of haemoglobin was determined by measuring 
the OD545 of the supernatant. The % haemolysis was calculated using the following formula: [(OD545 of sample − 
OD545 of negative control)/(OD545 of positive control − OD545 of negative control)] × 100.
Purification of ChoA protein. The choA gene, from B. vulgatus, was cloned into pTRC99a-HIS, a pTR-
C99a-based vector that adds a tag encoding a N-terminal 6xHis tag to the cloned gene. An overnight culture of 
E. coli EPI300 containing pTRC99a-6His-choA was diluted 1/100 into 50 ml LB broth, and grown to an OD600 
of 0.5. At this point 100 μM IPTG was added to induce choA expression, and the culture was incubated at 37 °C 
for a further 3 h. The cells were harvested by centrifugation for 10 mins, 1500 g, at 4 °C and the cell pellets were 
re-suspended in 2.5 ml ice cold 100 mM Tris–HCl, 1 mM EDTA, pH8 with lysozyme (100 μg ml−1) and incubated 
on ice for 30 min. At this point 10 mM MgCl2 and 50 μg ml−1 DNase I were added and the suspension was left 
for a further 15 min on ice. The cells were then lysed by 3 x freeze thaw cycles (−80 °C to 37 °C) and the lysate 
was centrifuged at 15000 g for 15 min at 4 °C. The pellet was kept as the insoluble fraction and the supernatant 
(soluble fraction) was filtered through a 0.45 μM filter (Sarstedt). The HisTrap affinity column (GE Healthcare) 
was prepared by washing with 5 ml dH2O, and then 5 ml 1x buffer A (4 mM Tris-HCl, 100 mM NaCl, pH 7.9). 
The bacterial soluble fraction was passed through the column, and the flow through was collected. The column 
was washed with 8–10 ml wash buffer (buffer A plus 10 mM imidazole) and the wash flow through was collected. 
The 6HIS-ChoA protein was eluted in buffer A containing 50 mM Imidazole and collected in 5 × 1 ml fractions. 
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Each fraction, along with insoluble, soluble, and flow through fractions, was loaded onto a 12.5% SDS-PAGE gel 
to visualise protein bands and protein concentration was determined by the Bradford assay (Sigma-Aldrich).
Immunoblot Analysis. E. coli EPI300 cells expressing the different choA orthologues were grown over-
night in LB broth with 20 µM IPTG. Cells were centrifuged and resuspended to an OD600 = 1 in PBS, as previ-
ously described. Cells were washed 2X in PBS, re-suspended in 100 μl of 1X SDS sample buffer before 10 μl of 
each sample was heated to 95 °C for 5 min and loaded onto a 12.5% SDS-PAGE gel. After separation, proteins 
were transferred to a nitrocellulose membrane, and the membranes were blocked in 1X TBS with 5% skim milk, 
for 1 h at room temperature, with gentle agitation. The membrane was washed 3 times in 1X TBS plus 0.05% 
Tween-20 (TBST) before primary rabbit anti-ChoA antibody (Biogenes) was added to the membrane (dilution 
1:1000) and incubated overnight at 4 °C, with gentle agitation. The membrane was washed 3 times in 1X TBST 
and anti-rabbit secondary antibody conjugated with horse-radish peroxidase (HRP) (Sigma-Aldrich) was added 
(dilution 1:80,000) and incubated with the membrane for 1 h at room temperature. The membrane was washed 
in 1X TBST and the protein bands visualised using SuperSignal West Pico Chemiluminescent Substrate (Thermo 
Scientific), according to manufacturer’s instructions.
Assay for NF-kB activity. E. coli cells, carrying the appropriate plasmid, were cultured for 24 h at 37 °C, 
with agitation, in the presence of 20 μM IPTG. The cells were removed via centrifugation, and the cell-free super-
natant was filtered through 0.2μm filter (Sarstedt). HEK-Blue™ hMD2-CD14 cells (containing a copy of the 
secreted alkaline phosphatase (SEAP) gene under the control of an NF-kB regulated promoter) were maintained 
in cell culture medium consisting of Dulbecco’s Modified Eagle’s Medium (DMEM) containing 4.5 g l−1 glucose 
and 2 mM L-glutamine (Gibco). The media was also supplemented with 10% (v/v) fetal bovine serum (Gibco), 
50 U ml−1 penicillin, 50 μg ml−1 streptomycin, 100 μg ml−1 Normocin (Invivogen), 200 µg ml−1 Hygromycin B 
Gold (Invivogen), and 100 µg ml−1 Zeocin (Invivogen). To start the assay 20 μl of the bacterial cell-free super-
natant was added to a flat bottomed 96-well plate and 180 μl of a 2.8 × 105 cells ml−1 suspension of HEK-Blue™ 
hMD2-CD14 cells, washed in PBS and resuspended in HEK-Blue™ Detection medium, was added to each well. 
The HEK-Blue™ Detection medium contains a chromogenic substrate for SEAP and NF-kB activity was deter-
mined by simply measuring the OD620 after incubating the cells at 37 °C for 12 h. Cell-free supernatants prepared 
from bacteria carrying the vector control were used as negative control.
Mass spectrometry. The presence of commendamide in culture supernatants was confirmed using mass 
spectrometry. Bacterial cultures were grown, and induced with 20 μM IPTG, for 24 h at 37 °C and the cells 
were removed by centrifugation at 1500 g for 15 min at room temperature. An equal volume of ethyl acetate 
(Sigma-Aldrich) was added to the cell-free culture supernatant and the solution was mixed thoroughly before 
the organic fraction was collected, and dried under vacuum. The samples were resuspended in acetonitrile and 
low-resolution mass spectra were recorded on a Waters Quattro Micro triple quadropole instrument in electros-
pray ionisation (ESI) mode using 50% acetonitrile-water containing 0.1% (v/v) formic acid as eluent. High resolu-
tion precise mass spectra (HRMS) were recorded on a Waters LCT Premier Tof LC-MS instrument in electrospray 
ionisation (ESI) mode using 50% acetonitrile-water containing 0.1% (v/v) formic acid as eluent.
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